Before the bell: DB, GM, AAPL, AZN

Posted Jul 2nd 2008 8:20AM by Melly Alazraki
Filed under: Before the Bell, Major Movement, Earnings Reports, Analyst Reports, Analyst Upgrades and Downgrades, Law, Apple Inc (AAPL), General Motors (GM), AT and T (T), Novartis AG ADS (NVS), Teva Pharm Indus ADR (TEVA)

Before the bell: Futures higher on SBUX, YHOO, ahead of inventory report

Deutsche Bank (NYSE: DB) shares are trading 4.2% higher in premarket action after the bank, seeking to calm investors, said it expects a profit in its second quarter.

While AT&T Inc. (NYSE: T) unveiled its pricing strategy for Apple Inc. (NASDAQ: AAPL)'s 3G iPhone to go on sale July 11 with a $199 and $299 (with contract) price points as expected, Canadians are outraged over Rogers Communications Inc. (NYSE: RCI)'s 3G iPhone rates and have created an online petition that collected over 19,000 signatures already.

AstraZeneca (NYSE: AZN) rose in Europe and is rising over 2.7% in premarket trading after winning a court case against Teva Pharmaceutical (NASDAQ: TEVA) and the Sandoz unit of Novartis (NYSE: NVS) over patents on its Seroquel schizophrenia drug.

A day after car sales were seen as "not as bad as expected," comes Merrill Lynch and downgrades General Motors (NYSE: GM). Shares are down over 3% in premarket trading.

Tags: aapl, azn, db, gm, inthenews, nvs, rci, t, teva